Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of KW-0761 in CCR4-positive adult T-cell leukemia-lymphoma
jRCT2080220744Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Jun 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mogamulizumab in adult T-cell leukemia-lymphoma (ATLL), sponsored by Kyowa Kirin.
02
Drugs
mogamulizumab
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCT2080220744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220744.